Pay in 4 interest-free payments of $7.25 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
This is a secondary-prevention result, not a general heart-health claim, and it belongs to the full obesity dose
Encouragingly, the 30 mg treatment group exhibited a consistent reduction across all markers except GFAP, indicating a potential anti-inflammatory effect
Older adults may be more likely to experience confusion, fainting, or falls from low blood sugar
The STEP 5 clinical trial showed that Wegovy causes sustained weight loss of 15.2% from baseline at 104 weeks (2 years) with weekly injection of semaglutide 2.4 mg
US$ 23.09
US$ 24.59
US$ 22.64
